| Indicators | Browse All

Oaktree Acquisition Corp. III Life Sciences (OACCW)

Los Angeles, United States | NasdaqGM
1.00 USD +0.07 (7.527%) ⇧ (July 13, 2026, 3:55 p.m. EDT)

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:01 a.m. EDT

This security presents a severe distress scenario with no viable investment thesis. The company is trading at a negative book value, indicating the liquidation value of assets is less than zero, while operating cash flow is deeply negative and earnings are contracting. The balance sheet is fragile with a current ratio below 1.0, signaling an inability to meet short-term obligations without external financing. Furthermore, the entity lacks any price history or dividend track record, rendering it impossible to assess historical performance or income potential. With no analyst recommendations and a complete absence of positive momentum or fundamental support, this is a clear avoidance signal.

None

Info Dump

Attribute Value
Address1 333 South Grand Avenue
Address2 28th Floor
Ask 0.5601
Ask Size 8
Bid 0.88
Bid Size 1
Book Value -0.294
City Los Angeles
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.0
Current Ratio 0.872
Custom Price Alert Confidence HIGH
Day High 1.2
Day Low 0.8301
Earnings Growth -0.16
Earnings Quarterly Growth -0.16
Ebitda Margins 0.0
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Two Week High 1.2
Fifty Two Week High Change -0.20000005
Fifty Two Week High Change Percent -0.1666667
Fifty Two Week Low 0.8301
Fifty Two Week Low Change 0.1699
Fifty Two Week Low Change Percent 0.20467414
Fifty Two Week Range 0.8301 - 1.2
Financial Currency USD
First Trade Date Milliseconds 1,783,690,200,000
Float Shares 18,458,955
Full Exchange Name NasdaqGM
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Industry
Industry Key
Ipo Expected Date 2,024-12-16
Language en-US
Long Business Summary Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Long Name Oaktree Acquisition Corp. III Life Sciences
Market us_market
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_1890819822
Net Income To Common 7,024,154
Open 0.99
Operating Cashflow -504,553
Operating Margins 0.0
Phone 213 830 6300
Previous Close 0.93
Price Hint 4
Price To Book -3.4013605
Profit Margins 0.0
Quick Ratio 0.786
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.06999999
Regular Market Change Percent 7.526881
Regular Market Day High 1.2
Regular Market Day Low 0.8301
Regular Market Day Range 0.8301 - 1.2
Regular Market Open 0.99
Regular Market Previous Close 0.93
Regular Market Price 1.0
Regular Market Time 1,783,972,535
Regular Market Volume 5,222
Sand P52 Week Change 0.20847368
Sector
Sector Key
Short Name Oaktree Acquisition Corp. III L
Source Interval 15
State CA
Symbol OACCW
Total Cash 1,276,930
Total Cash Per Share 0.052
Total Debt 11,824
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Peg Ratio None
Triggerable 1
Type Disp Equity
Volume 5,222
Website https://www.oaktreeacquisitioncorp.com/oac-iii
Zip 90,071